before treatment, immediately after the first treatment, and 3, 6, and 12 months after the fourth treatment. Patient satisfaction scores were obtained at each follow-up visit. RESULTS. Mild to moderate improvement in treated facial rhytides was observed in all patients. Increased dermal collagen was seen 6 months after four successive treatments. Patient satisfaction scores paralleled the photographic and histopathologic changes seen. Side effects were limited to transient erythema, edema, and postinflammatory hyperpigmentation. CONCLUSION. The nonablative 1,450-nm diode laser is safe and effective for the treatment of mild-to-moderate facial rhytides.
THIS WORK WAS SUPPORTED BY A RESEARCH GRANT BY CANDELA LASER CORP.
ABLATIVE LASER resurfacing is a well-accepted treatment modality for facial rejuvenation, as it can predictably improve the appearance of photoinduced rhytides. [1] [2] [3] [4] [5] [6] The primary mechanism for wrinkle effacement that continues several months after an ablative laser skin resurfacing procedure is based on the creation of a controlled thermal injury in the dermis that induces neocollagenesis. 1, 7, 8 CO 2 and erbium laser-induced epidermal ablation with loss of barrier function, however, typically leads to extended postoperative recovery periods. Untoward side effects may include prolonged erythema, pigmentary alterations, infection, and, in rare cases, scarring. [9] [10] [11] As a consequence of these risks, great interest has been shown for less invasive methods to treat photoinduced rhytides effectively. Several laser or light-based systems have subsequently been developed that demonstrate efficacy in the treatment of photodamaged and scarred skin. These systems include the 585-nm pulsed dye, 12 980-nm diode, 13 1,064-nm Nd:YAG, 14 1,320-nm Nd:YAG, [15] [16] [17] [18] [19] 1,450-nm diode, 19, 20 1,540-nm Erbium:glass 21, 22 lasers, and an intense pulsed light source. [23] [24] [25] Each system combines epidermal surface cooling with deeply penetrating wavelengths that selectively target water-containing tissue, thereby creating a selective thermal injury in the dermis. Although previous reports have demonstrated the short-term efficacy of a 1,450-nm diode laser for the treatment of mild to moderate facial rhytides, 26, 27 no prior study has evaluated these patients beyond 6 months after laser treatment. The objective of this controlled study, therefore, was to evaluate the longterm efficacy and safety of a 1,450-nm diode laser for nonablative dermal remodeling of mild-to-moderate perioral and periorbital photoinduced rhytides.
Methods
Twenty-five females (ages 35 to 68; mean of 50 years, skin phototypes I-III) with mild to moderate rhytides (perioral, N 5 6; periorbital, N 5 19) were entered in the study. Exclusion criteria for study entry included concomitant treatments (other than topical therapy) to the involved skin areas, history of keloid scarring, isotretinoin use within 1 year of study initiation, ablative resurfacing procedures within 2 years of study initiation, photosensitivity, or immunosuppression. , and a pulse duration of 210 ms. Skin surface cooling was achieved with a dynamic cooling device (tetrafluoroethane, À 441C) using 10-ms precooling, 30-ms intracooling, and 20-ms posttreatment cooling (60-ms total). After topical application of anesthetic cream (ElaMax-5; Ferndale Laboratories, Inc, Ferndale, MI) without occlusion for 20 to 30 minutes, a single pass of nonoverlapping laser pulses was delivered to randomly selected periorbital or perioral areas, producing a clinical endpoint of mild erythema and swelling without vesiculation. Symmetrical matched areas were left untreated to serve as controls.
Photographic documentation using identical camera settings, lighting, and patient positioning and calculation of average clinical rhytide scores by three independent assessors were obtained at baseline and at 1, 3, 6, and 12 months after the final treatment. Rhytides were categorized based on an established nine-point scale: mild 5 class I (score 1-3), moderate 5 class II (score 4-6), or severe 5 class III (score 7-9) ( Table 1) . Patient satisfaction surveys (ratings: not satisfied, somewhat satisfied, satisfied) were also obtained at each follow-up visit.
Differences between the pretreatment and posttreatment mean clinical scores of treated versus untreated regions were tabulated and compared. Wrinkle severity and the SD at baseline and at follow-up visits were calculated for both the treatment and control sides. Student's t-test (paired samples) was performed comparing wrinkle severity at baseline with followup visits for both treatment and control areas. A twotailed P value less than 0.05 was considered significant.
In five patients, skin biopsies were obtained within laser-treated and nontreated (control) sites for histologic evaluation at baseline, immediately following the first treatment, and at 1, 3, 6, and 12 months after the final laser treatment. All specimens were processed for masked evaluation by a board-certified dermatopathologist (M.C.W.). Side effects and complications were recorded at each treatment and follow-up visit. (Figures 1-3 and Tables 2  and 3 ).
Results

Maximum clinical improvement
Histologic evaluation demonstrated increased dermal collagen 6 months after the final laser procedure. Further neocollagenesis was not observed at the 12-month follow-up visit (Figure 2A, B) . No such improvement was observed in nontreated (control) skin biopsies.
The treatment was well tolerated, with patients describing the procedure as mildly to moderately uncomfortable. Posttreatment erythema was observed in all patients and persisted for 2 to 36 hours (average of 6.8 hours) after the procedure. Shallow vesicles that spontaneously resolved within 48 hours developed in two patients (2% of total 100 treatment sessions). Postinflammatory hyperpigmentation was observed in 18 follow-up assessments in 16 patients (18% of the total 100 treatments), with most occurring after the second treatment session. All cases of dyspigmentation resolved completely with topical bleaching agents within 4 to 21 weeks (average of 14 weeks). No hypopigmentation or hypertrophic scarring was observed in any patient throughout the 12-month study period. Patient satisfaction surveys revealed that 32% of patients were fully satisfied with the treatment and 56% were somewhat satisfied. The three patients (12%) who were not satisfied each 
Discussion
This study demonstrates that the 1,450-nm diode laser is a safe and effective noninvasive technique to induce modest long-term clinical improvement of mild-tomoderate photoinduced facial rhytides. The periorbital area was more responsive to treatment than the perioral area at the laser parameters chosen--a finding consistent with results obtained using other nonablative systems. 22 The relative thinness of periocular skin may result in increased thermal injury (and, hence, amplify collagen remodeling) in the dermis and/or simply render visualization of collagen enhancement more apparent. The continued (peak) clinical improvement seen over the first 6 months after the series of laser treatments, however, diminished slightly by the 12-month follow-up visit.
The results of this study are consistent with previous reports using a 1,450-nm diode laser for the treatment of facial rhytides. Goldberg and Samady 23 demonstrated clinical improvement in 13 of 20 patients 6 months after two to four laser treatments. No improvement in facial rhytides was observed in the 24 demonstrated statistically significant mean wrinkle improvement of 2.3 (range 0 to 4, with 4 representing severe wrinkling) at baseline to 1.8 at the 5-month follow-up visit.
The significant incidence of hyperpigmentation observed in our study was interesting as the 1,450-nm wavelength is not well absorbed by melanin. It is probable that the postinflammatory hyperpigmentation was related to the amount (60 ms total) of dynamic cooling used during the laser treatments rather than to the wavelength or fluence delivered. In addition, the fact that most cases of hyperpigmentation were observed after the second treatment (delivered 3 weeks after the first) indicates that the treatment intervals may have been too short. Indeed, in another 1,450-nm diode study currently being conducted by the authors, reduction of dynamic cooling from 60 to 50 ms and delivery of treatments at 4-to 6-week time intervals have dramatically reduced the rate of postinflammatory hyperpigmentation.
Conclusions
Less invasive techniques for rejuvenation of photodamaged skin are becoming more popular in the medical community because of high public demand and the desire to provide good clinical outcomes while minimizing side effects and recovery periods. Although the degree of wrinkle effacement has not equaled that seen after ablative laser skin resurfacing, nonablative laser systems are an ideal treatment choice for those patients who are unwilling or unable to undergo the prolonged postoperative recovery associated with ablative cutaneous procedures. Further study is warranted to determine further optimal treatment parameters and/or combination with other modalities (e.g., chemical peels, microdermabrasion) to effect more prolonged or enhanced improvement. 
